Now showing items 31-31 of 31
Immunoglobulin D myeloma: Clinical features and outcome in the era of novel agents
Objectives: Immunoglobulin D (IgD) multiple myeloma is an uncommon variant of the disease probably associated with poorer prognosis. However, data on IgD myeloma patients treated in the novel agent era are lacking. Methods: ...